https://orcid.org/0000-0002-2259-4028
References
- Christenson GA, Popkin MK, Mackenzie TB, et al. Lithium treatment of chronic hair pulling. J Clin Psychiatry. 1991 Mar;52(3):116–120. PMID: 1900831.
- Mobini S, Chiang R, Al-Ruwaitea AS, et al. Effect of central 5-hydroxytryptamine depletion on inter-temporal choice: a quantitative analysis. Psychopharmacology (Berl). 2000 Apr;149(3):313–318. PMID: 10823413. doi: 10.1007/s002130000385
- Woods DW, Flessner CA, Franklin ME, et al. The Trichotillomania Impact Project (TIP): exploring phenomenology, functional impairment, and treatment utilization. J Clin Psychiatry. 2006 Dec;67(12):1877–1888. PMID: 17194265. doi: 10.4088/JCP.v67n1207
- Bloch MH, Landeros-Weisenberger A, Dombrowski P, et al. Systematic review: pharmacological and behavioral treatment for trichotillomania. Biol Psychiatry. 2007 Oct 15;62(8):839–846. PMID: 17727824 doi: 10.1016/j.biopsych.2007.05.019
- Grados MA, Atkins EB, Kovacikova GI, et al. A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders. Psychol Res Behav Manag. 2015 Apr 28;8:115–131. PMID: 25995654. doi: 10.2147/PRBM.S58601
- Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2009 Jul;66(7):756–763. PMID: 19581567. doi: 10.1001/archgenpsychiatry.2009.60
- Bloch MH, Panza KE, Grant JE, et al. N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial. J Am Acad Child Adolesc Psychiatry. 2013 Mar;52(3):231–240. PMCID: PMC3745012. doi: 10.1016/j.jaac.2012.12.020
- De Sousa A. An open-label pilot study of naltrexone in childhood-onset trichotillomania. J Child Adolesc Psychopharmacol. 2008 Feb;18(1):30–33. PMID: 18294086. doi: 10.1089/cap.2006.0111
- Grant JE, Odlaug BL, Schreiber LR, et al. The opiate antagonist, naltrexone, in the treatment of trichotillomania: results of a double-blind, placebo-controlled study. J Clin Psychopharmacol. 2014 Feb;34(1):134–138. PMID: 24145220. doi: 10.1097/JCP.0000000000000037
- Grant JE, Odlaug BL, Chamberlain SR, et al. Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study. Psychopharmacology (Berl.). 2011 Dec;218(3):493–502. PMID: 21590520. doi: 10.1007/s00213-011-2347-8
- Ozcan YD, Ozcan H, Ensari H. Efficacy of hydroxyzine in the treatment of trichotillomania: an open-label study. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology. 2003;13:19–22. http://www.psikofarmakoloji.org/pdf/13_1_4.pdf
- Oliver G, Dean O, Camfield D, et al. N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review. Clin Psychopharmacol Neurosci. 2015 Apr 30;13(1):12–24. PMCID: PMC4423164. doi: 10.9758/cpn.2015.13.1.12
- Behl A, Swami G, Sircar SS, et al. Relationship of possible stress-related biochemical markers to oxidative/antioxidative status in obsessive-compulsive disorder. Neuropsychobiology. 2010;61(4):210–214. PMID: 20389131. doi: 10.1159/000306591
- Odlaug BL, Grant JE. N-acetyl cysteine in the treatment of grooming disorders. J Clin Psychopharmacol. 2007 Apr;27(2):227–229. PMID: 17414258. doi: 10.1097/01.jcp.0000264976.86990.00